Login to Your Account

Eisai Gaining Cancer Portfolio In $3.9B MGI Acquisition

By Trista Morrison

Tuesday, December 11, 2007
Less than two weeks after placating the rumor mill by officially announcing that it was evaluating "strategic alternatives," MGI Pharma Inc. agreed to be acquired by Eisai Co. Ltd. for $41 per share, or about $3.9 billion in cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription